logo
Select company
Select metric
-183.49%Return on Equity
VS
Market
7
Sector
20
Industry
24
History
100
$ 2.98Close
$ 1.6 - $ 3.99 52-Week Range
Ticker Information

Ticker

NRXS

Company Name

NEURAXIS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

NEURAXIS INC - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NRXS - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ 4.25M$ -7.8M-183.49%
3/31/2025$ 258.48K$ -8.82M-3413.95%
12/31/2024$ 2.07M$ -8.45M-408.79%
9/30/2024$ -1.79M$ -12.11M0%
6/30/2024$ -5.26M$ -15.26M0%
3/31/2024$ -3.18M$ -14.57M0%
12/31/2023$ -1.4M$ -14.63M0%
9/30/2023$ -1.06M$ -9.33M0%
6/30/2023$ -9.98M$ 00%
3/31/2023$ -7.75M$ 00%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NEURAXIS INC's latest trailing twelve months (TTM) ROE stands at 0%.
  • Over the past 5 years, NEURAXIS INC's average ROE has been -1335.41%.
  • The median ROE for NEURAXIS INC during this period was -408.79%
  • NEURAXIS INC reached its highest ROE over the past 5 years at -183.49%.
  • The lowest ROE recorded by NEURAXIS INC in the same timeframe -3413.95%

NEURAXIS INC's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
CAMP : CAMP4 THERAPEUTICS CORP -129.5%DYAI : DYADIC INTERNATIONAL INC -LPCN : LIPOCINE INC -26.31%TRAW : TRAWS PHARMA INC 1064.03%LSTA : LISATA THERAPEUTICS INC -89.99%STTK : SHATTUCK LABS INC -107.88%SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC -LGVN : LONGEVERON INC -147.66%BOLT : BOLT BIOTHERAPEUTICS INC -130.56%CLSD : CLEARSIDE BIOMEDICAL INC -

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for NEURAXIS INC is calculated as follows: Net Inc. Cmn. [ $ -3.03M ] / Equity [ $ -825.66K ]
(=) ROE [ 0% ]

NRXS - Return on Equity, Last 5 years

-3413.95%

Minimum

Mar 31, 2025

-183.49%

Maximum

Jun 30, 2025

-1335.41%

Average

-408.79%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.13K
min-66.24%
max73.25%
average1.63%
median6.53%
std22.52%